{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:47Z","timestamp":1791357287466,"version":"4.3.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1366,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1365-2133.2011.10649.x","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T05:30:43Z","timestamp":1316669443000},"page":"322-330","source":"Crossref","is-referenced-by-count":40,"title":["Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis"],"prefix":"10.1093","volume":"166","author":[{"given":"M.","family":"Tohyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shirakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,12,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB1|cit1","first-page":"3","article-title":"Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review)","volume":"19","author":"Paquet","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis","volume":"47","author":"Correia","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.1993.01680250078010","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2133.1985.tb02356.x","article-title":"Involvement of macrophages in the pathology of toxic epidermal necrolysis","volume":"113","author":"Roujeau","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archderm.1994.01690050073012","article-title":"Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis","volume":"130","author":"Paquet","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000372-200010000-00005","article-title":"Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis","volume":"22","author":"Paquet","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0167-5699(96)10029-3","article-title":"Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation","volume":"17","author":"Ziegler-Heitbrock","year":"1996","journal-title":"Immunol Today"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.it.2005.06.003","article-title":"Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation","volume":"26","author":"Myers","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1532\/IJH97.05120","article-title":"Tumor necrosis factor\/tumor necrosis factor receptor family members that positively regulate immunity","volume":"83","author":"So","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB15|cit15","first-page":"367","article-title":"Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors","volume":"6","author":"Lerner","year":"1974","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","article-title":"The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF","volume":"168","author":"Belge","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.exphem.2004.05.027","article-title":"Antitumor response of CD14+\/CD16+ monocyte subpopulation","volume":"32","author":"Szaflarska","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1189\/jlb.69.1.11","article-title":"Heterogeneity of human peripheral blood monocyte subsets","volume":"69","author":"Grage-Griebenow","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","article-title":"Characterization of human blood dendritic cell subsets","volume":"100","author":"MacDonald","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","article-title":"CD28\/B7 system of T cell costimulation","volume":"14","author":"Lenschow","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<45::AID-IMMU45>3.0.CO;2-I","article-title":"ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1","volume":"29","author":"Deeths","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/clim.2000.4902","article-title":"Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging","volume":"96","author":"Laux","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1073\/pnas.0306567101","article-title":"Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses","volume":"101","author":"Bukczynski","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/eji.1830240943","article-title":"Molecular and biological characterization of human 4-1BB and its ligand","volume":"24","author":"Alderson","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/smim.1998.0157","article-title":"Role of 4-1BB in immune responses","volume":"10","author":"Vinay","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/MCB.18.1.558","article-title":"4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB","volume":"18","author":"Arch","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.162.9.5037","article-title":"Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal","volume":"162","author":"Takahashi","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.4049\/jimmunol.169.9.4882","article-title":"4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1","volume":"169","author":"Lee","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/eji.200323996","article-title":"4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1","volume":"33","author":"Lee","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/intimm\/dxm106","article-title":"Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80\/CD86 and can reactivate anergic T cells","volume":"19","author":"Habib-Agahi","year":"2007","journal-title":"Int Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.186.1.47","article-title":"4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses","volume":"186","author":"Shuford","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.190.10.1535","article-title":"Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy","volume":"190","author":"Mittler","year":"1999","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.4049\/jimmunol.167.9.4981","article-title":"Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases","volume":"167","author":"Nozawa","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/15258160152509064","article-title":"Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8(+) T cells","volume":"10","author":"Kim","year":"2001","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.4049\/jimmunol.179.7.4910","article-title":"4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy","volume":"179","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1116::AID-IMMU1116>3.0.CO;2-A","article-title":"Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway","volume":"28","author":"Melero","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/92.11.931","article-title":"Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long-term remission of liver metastases in a mouse model","volume":"92","author":"Martinet","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/mthe.2000.0086","article-title":"Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation","volume":"2","author":"Chen","year":"2000","journal-title":"Mol Ther"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI0214184","article-title":"Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors","volume":"109","author":"Wilcox","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ni798","article-title":"In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses","volume":"3","author":"Halstead","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2007-07-104604","article-title":"Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific \u2018effector memory\u2019 (CD28(\u2212) CD45RA(HI)) CD8(+) T cells","volume":"110","author":"Waller","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.0990011","article-title":"Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease","volume":"182","author":"Lin","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI32426","article-title":"Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent","volume":"117","author":"Zhang","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2249.2004.02565.x","article-title":"Human macrophages kill human mesangial cells by Fas-L-induced apoptosis when triggered by antibody via CD16","volume":"137","author":"Boyle","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jcp.52.12.910","article-title":"A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation","volume":"52","author":"Sviland","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jcp.55.2.127","article-title":"The detection of apoptosis in a human in vitro skin explant assay for graft versus host reactions","volume":"55","author":"Jarvis","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB50|cit50","first-page":"65","article-title":"Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients","volume":"13","author":"Dickinson","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":"Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2011.10649.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1532\/IJH97.A10613","article-title":"Study of relieving graft-versus-host disease by blocking CD137-CD137 ligand costimulatory pathway in vitro","volume":"86","author":"Xu","year":"2007","journal-title":"Int J Hematol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10649.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10649.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T21:11:25Z","timestamp":1686345085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/2\/322\/6613673"}},"subtitle":["CD14+ CD16+ monocytes in SJS\/TEN"],"short-title":[],"issued":{"date-parts":[[2011,12,5]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10649.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,5]]}}}